Literature DB >> 12438216

Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.

Yasuhiro Yamada1, Kazuya Hata, Yoshinobu Hirose, Akira Hara, Shigeyuki Sugie, Toshiya Kuno, Naoki Yoshimi, Takuji Tanaka, Hideki Mori.   

Abstract

Mutations in the human adenomatous polyposis coli (APC) gene are causative for familial adenomatous polyposis (FAP), a rare condition in which numerous colonic polyps arise during puberty and, if left untreated, lead to colon cancer. Mouse model for human FAP, Apc(Min/+) mouse, contains a truncating mutation in the Apc gene and spontaneously develops intestinal adenomas. However, the distribution of tumors along the intestine found in Apc(Min/+) mice is different from that in human FAP. A majority of intestinal polyps in the Apc(Min/+) mice is known to be located in the small intestine but rarely detected in the colon. We report here that adult Apc(Min/+) mice develop dozens of microadenomatous lesions in the colon (>20 lesions/colon). Surprisingly, the vast majority of such adenomatous lesions consisting of colonic crypts were <300 microm in their greatest dimension, whereas lesions in the small intestine showed various sizes. The allelic loss analysis revealed that these adenomatous crypts in the colon have already lost the remaining allele of Apc. Such findings suggest that, in contrast to tumorigenesis in the small intestine, loss of heterozygosity of the Apc gene is not sufficient for tumor development in the colon of Apc(Min/+) mice. Our results may give an account for the low incidence of colonic tumors in Apc(Min/+) mice.

Entities:  

Mesh:

Year:  2002        PMID: 12438216

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Essential requirement for β-arrestin2 in mouse intestinal tumors with elevated Wnt signaling.

Authors:  Caroline Bonnans; Maud Flacelière; Fanny Grillet; Christelle Dantec; Jean-Pierre Desvignes; Julie Pannequin; Dany Severac; Emeric Dubois; Frédéric Bibeau; Virginie Escriou; Philippe Crespy; Laurent Journot; Frédéric Hollande; Dominique Joubert
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-06       Impact factor: 11.205

2.  Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium.

Authors:  Akihiro Hirata; Jochen Utikal; Satoshi Yamashita; Hitomi Aoki; Akira Watanabe; Takuya Yamamoto; Hideyuki Okano; Nabeel Bardeesy; Takahiro Kunisada; Toshikazu Ushijima; Akira Hara; Rudolf Jaenisch; Konrad Hochedlinger; Yasuhiro Yamada
Journal:  Development       Date:  2013-01-01       Impact factor: 6.868

3.  Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis.

Authors:  Wook-Jin Chae; Thomas F Gibson; Daniel Zelterman; Liming Hao; Octavian Henegariu; Alfred L M Bothwell
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

4.  Foxl1 is a mesenchymal Modifier of Min in carcinogenesis of stomach and colon.

Authors:  Nathalie Perreault; Sara D Sackett; Jonathan P Katz; Emma E Furth; Klaus H Kaestner
Journal:  Genes Dev       Date:  2005-01-13       Impact factor: 11.361

5.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.

Authors:  Yasuhiro Yamada; Laurie Jackson-Grusby; Heinz Linhart; Alex Meissner; Amir Eden; Haijiang Lin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

6.  Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.

Authors:  Ki Taek Nam; Hyuk-Joon Lee; J Joshua Smith; Lynne A Lapierre; Vidya P Kamath; Xi Chen; Bruce J Aronow; Timothy J Yeatman; Sheela G Bhartur; Benjamin C Calhoun; Brian Condie; Nancy R Manley; R Daniel Beauchamp; Robert J Coffey; James R Goldenring
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

7.  Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.

Authors:  Hui Xiao; Weiguo Yin; Mohammed A Khan; Muhammet F Gulen; Hang Zhou; Ho Pan Sham; Kevan Jacobson; Bruce A Vallance; Xiaoxia Li
Journal:  Gastroenterology       Date:  2010-04-21       Impact factor: 22.682

8.  Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling.

Authors:  Angela J Glading; Mark H Ginsberg
Journal:  Dis Model Mech       Date:  2009-12-09       Impact factor: 5.758

9.  Widespread hyperplasia induced by transgenic TGFalpha in ApcMin mice is associated with only regional effects on tumorigenesis.

Authors:  Andrea Bilger; Ruth Sullivan; Amy J Prunuske; Linda Clipson; Norman R Drinkwater; William F Dove
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

10.  Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing.

Authors:  Heinz G Linhart; Haijiang Lin; Yasuhiro Yamada; Eva Moran; Eveline J Steine; Sumita Gokhale; Grace Lo; Erika Cantu; Mathias Ehrich; Timothy He; Alex Meissner; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2007-12-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.